After a
five-year contraction in employer healthcare spending growth, medical
inflation in the U.S. is projected to rise to 6.8 percent in 2015,
according to PwC’s Health Research Institute (HRI). It is critical for
stakeholders positioning themselves for 2015 and beyond to consider and
address the associated trends and implications, from the reach of the
stronger economy into the health sector, releasing a pent-up demand for
care and services. Four factors PwC will discuss in detail that "inflate" the medical cost trend in 2015: (1) Economic upswing; (2) Specialty drugs; (3) Physician employment; and (4) Information technology investments for large-scale health system mergers and acquisitions. PwC will also address three factors that serve to "deflate" the 2015 medical cost trend: (1) “Systemness” – Understanding that a well-functioning whole is greater than its disparate parts, and reducing redundancies lowers operating costs; (2) Healthcare price shopping; and (3) Risk-based payments. Please join us Tuesday, July 15th, 2014 at 1:00 PM Eastern as Benjamin Isgur, Director of PwC's Health Research Institute takes us behind the numbers to examine employer 2015 medical cost trends and implications for stakeholders. He will discuss in detail PwC research findings, expand on individual factors that will "deflate" and inflate components of the medical cost trend for 2015, and address strategic implications for health plans, providers, employers, consumers and other stakeholders. Click here for detailed information and to register or call 209.577.4888. |
||
Return to HealthExecWire Archive Menu
|